Literature DB >> 33500564

The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes.

Valentin Sencio1,2,3,4,5, Marina Gomes Machado1,2,3,4,5, François Trottein6,7,8,9,10.   

Abstract

Bacteria that colonize the human gastrointestinal tract are essential for good health. The gut microbiota has a critical role in pulmonary immunity and host's defense against viral respiratory infections. The gut microbiota's composition and function can be profoundly affected in many disease settings, including acute infections, and these changes can aggravate the severity of the disease. Here, we discuss mechanisms by which the gut microbiota arms the lung to control viral respiratory infections. We summarize the impact of viral respiratory infections on the gut microbiota and discuss the potential mechanisms leading to alterations of gut microbiota's composition and functions. We also discuss the effects of gut microbial imbalance on disease outcomes, including gastrointestinal disorders and secondary bacterial infections. Lastly, we discuss the potential role of the lung-gut axis in coronavirus disease 2019.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33500564      PMCID: PMC7835650          DOI: 10.1038/s41385-020-00361-8

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  108 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 2.  Host-gut microbiota metabolic interactions.

Authors:  Jeremy K Nicholson; Elaine Holmes; James Kinross; Remy Burcelin; Glenn Gibson; Wei Jia; Sven Pettersson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

Review 3.  The cross talk between microbiota and the immune system: metabolites take center stage.

Authors:  Hagit Shapiro; Christoph A Thaiss; Maayan Levy; Eran Elinav
Journal:  Curr Opin Immunol       Date:  2014-07-26       Impact factor: 7.486

Review 4.  The microbiome and innate immunity.

Authors:  Christoph A Thaiss; Niv Zmora; Maayan Levy; Eran Elinav
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

Review 5.  The Human Gut Microbiome: From Association to Modulation.

Authors:  Thomas S B Schmidt; Jeroen Raes; Peer Bork
Journal:  Cell       Date:  2018-03-08       Impact factor: 41.582

Review 6.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 7.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

Review 8.  Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.

Authors:  Joseph M Pickard; Melody Y Zeng; Roberta Caruso; Gabriel Núñez
Journal:  Immunol Rev       Date:  2017-09       Impact factor: 12.988

Review 9.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.

Authors:  Ara Koh; Filipe De Vadder; Petia Kovatcheva-Datchary; Fredrik Bäckhed
Journal:  Cell       Date:  2016-06-02       Impact factor: 41.582

10.  Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

Authors:  Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

View more
  47 in total

Review 1.  Long-distance relationships - regulation of systemic host defense against infections by the gut microbiota.

Authors:  Jared Schlechte; Isla Skalosky; Markus B Geuking; Braedon McDonald
Journal:  Mucosal Immunol       Date:  2022-06-22       Impact factor: 8.701

Review 2.  Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors.

Authors:  Roberta Rovito; Matteo Augello; Assaf Ben-Haim; Valeria Bono; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 3.  The Impact of Air Pollution on Gut Microbiota and Children's Health: An Expert Consensus.

Authors:  Eddy Fadlyana; Dewi Sumaryani Soemarko; Anang Endaryanto; Budi Haryanto; Andy Darma; Dian Kusuma Dewi; Dian Novita Chandra; Budi Hartono; Sonia Buftheim; Erika Wasito; Tonny Sundjaya; Ray Wagiu Basrowi
Journal:  Children (Basel)       Date:  2022-05-24

Review 4.  Insights on the Gut-Mesentery-Lung Axis in Pulmonary Arterial Hypertension: A Poorly Investigated Crossroad.

Authors:  Suellen Darc Oliveira
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-03-17       Impact factor: 10.514

Review 5.  The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention.

Authors:  Nathan Cruz; George A Abernathy; Armand E K Dichosa; Anand Kumar
Journal:  Infect Immun       Date:  2022-04-06       Impact factor: 3.609

Review 6.  The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.

Authors:  Qin Ning; Di Wu; Xiaojing Wang; Dong Xi; Tao Chen; Guang Chen; Hongwu Wang; Huiling Lu; Ming Wang; Lin Zhu; Junjian Hu; Tingting Liu; Ke Ma; Meifang Han; Xiaoping Luo
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

7.  Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.

Authors:  Valentin Sencio; Alexandre Gallerand; Marina Gomes Machado; Lucie Deruyter; Séverine Heumel; Daphnée Soulard; Johanna Barthelemy; Céline Cuinat; Angelica T Vieira; Adeline Barthelemy; Luciana P Tavares; Rodolphe Guinamard; Stoyan Ivanov; Corinne Grangette; Mauro M Teixeira; Benoit Foligné; Isabelle Wolowczuk; Ronan Le Goffic; Muriel Thomas; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

8.  Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?

Authors:  Ramachandran Vignesh; Vijayakumar Velu; Sripathi M Sureban
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

Review 9.  Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation.

Authors:  Muhammad Akhtar; Yan Chen; Ziyu Ma; Xiaolong Zhang; Deshi Shi; Jawaria A Khan; Huazhen Liu
Journal:  Anim Nutr       Date:  2021-12-29

Review 10.  The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome.

Authors:  Denise Battaglini; Chiara Robba; Andrea Fedele; Sebastian Trancǎ; Samir Giuseppe Sukkar; Vincenzo Di Pilato; Matteo Bassetti; Daniele Roberto Giacobbe; Antonio Vena; Nicolò Patroniti; Lorenzo Ball; Iole Brunetti; Antoni Torres Martí; Patricia Rieken Macedo Rocco; Paolo Pelosi
Journal:  Front Med (Lausanne)       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.